NCT01713972 2019-03-01
Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
Ohio State University Comprehensive Cancer Center
University of Chicago
National Cancer Centre, Singapore
National Cancer Institute (NCI)